Foo Lisa Y sold $6.4M of THC

Foo Lisa Y (EVP, Chief Operating Officer) sold 24,000 shares of TENET HEALTHCARE CORP (THC) at $266.32 ($6.39M total) on 2026-08-31.

Original reporting
SEC EDGAR · Foo Lisa Y
Published Sep 1, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 2, 2026, 7:26 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$THC
Bearish
medium confidence
Mentioned
$THC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCBearishLow
01

Why it matters

The sale reduces insider ownership and could be interpreted as a lack of confidence, prompting short interest.

02

Market read

Insider sell of $6.4M is material and may influence short‑term price action.

03

What to watch

Potential upcoming corporate actions or personal liquidity needs not disclosed.

Relevance 6/10Novelty 7/10Timing: post‑market filing on 2026‑08‑31

Background

Tenet Healthcare filed a Form 4 reporting an executive's open‑market sale of shares.

Company-level read

Ticker impact

$THCBearishMedium confidence
Context

SEC Form 4 disclosed EVP Foo Lisa Y sold 24,000 shares for $6.39M, reducing her stake to 8,053 shares.

Expected impact

Potential short-term downside of 2‑4% as market digests the sale.

Evidence & confidence

Exec-level insider sale exceeding $5M is material; investors often view such sales as bearish.

Market effects

May raise concerns for healthcare sector if multiple insiders sell, but limited broader impact.

Primarily U.S. market; no significant regional effect.

Limited to Tenet Healthcare investors; not a global driver.

Counterpoint

Insider may be diversifying; sale does not necessarily reflect company fundamentals.

Key entities

  • Tenet Healthcare Corp

    U.S. listed healthcare services provider (NYSE:THC).

  • Foo Lisa Y

    EVP, Chief Operating Officer of Tenet Healthcare.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HCAMed

Hospital Stocks Soared as Democrats Took Congress

HCA Healthcare (HCA) rose 10.34% to $510.70 on November 4, 2026, following Democratic gains in the U.S. election. Investors anticipate potential policy changes favoring hospitals and Medicaid insurers. Universal Health Services (UHS) and Tenet Healthcare (THC) also saw significant gains. HCA's stock is now valued at $106.68 billion, but analysts warn of potential downside risks if policy changes do not materialize.

$THCHighAI 8/10

Mizuho raises Tenet Healthcare stock price target on strong results

Mizuho increased its price target for Tenet Healthcare (NYSE:THC) to $305 from $290, citing strong quarterly results and raised 2026 EBITDA estimates. The stock trades near its 52-week high after a 49% six-month surge. Tenet reported Q3 2026 EPS of $6.64, beating estimates, and raised its full-year EBITDA outlook. Guggenheim maintained a Buy rating with a slightly lowered target of $306.

$THCMed

Tenet Healthcare Q3 Earnings Call Highlights

Tenet Healthcare (THC) reported Q3 earnings, with hospital segment showing 3.2% growth in admissions and 11% adjusted EBITDA increase. Revenue per admission rose 0.2% YoY. Exchange admissions and revenues declined 18%. Conifer transition activities contributed $147M, with $450M expected in 2026. Tenet generated $1.1B in adjusted free cash flow and repurchased 970K shares.